Russell Investments Group Ltd. lowered its stake in Utah Medical Products, Inc. (NASDAQ:UTMD - Free Report) by 14.4% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 43,201 shares of the medical instruments supplier's stock after selling 7,265 shares during the quarter. Russell Investments Group Ltd. owned 1.27% of Utah Medical Products worth $2,656,000 at the end of the most recent quarter.
A number of other institutional investors have also recently made changes to their positions in UTMD. Golden State Wealth Management LLC bought a new stake in Utah Medical Products during the 4th quarter valued at $31,000. R Squared Ltd purchased a new position in shares of Utah Medical Products in the fourth quarter valued at about $49,000. BNP Paribas Financial Markets raised its stake in shares of Utah Medical Products by 102.7% during the third quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier's stock valued at $75,000 after acquiring an additional 566 shares during the last quarter. New Age Alpha Advisors LLC purchased a new stake in shares of Utah Medical Products during the fourth quarter worth about $101,000. Finally, Wells Fargo & Company MN grew its stake in shares of Utah Medical Products by 24.9% in the fourth quarter. Wells Fargo & Company MN now owns 1,927 shares of the medical instruments supplier's stock worth $118,000 after purchasing an additional 384 shares during the last quarter. Hedge funds and other institutional investors own 69.60% of the company's stock.
Utah Medical Products Price Performance
NASDAQ:UTMD traded down $0.10 during mid-day trading on Friday, reaching $52.30. 10,925 shares of the company's stock traded hands, compared to its average volume of 20,165. Utah Medical Products, Inc. has a 12-month low of $52.27 and a 12-month high of $77.33. The company has a 50 day moving average price of $57.18 and a 200-day moving average price of $61.35. The firm has a market capitalization of $171.65 million, a price-to-earnings ratio of 13.24 and a beta of 0.17.
Utah Medical Products (NASDAQ:UTMD - Get Free Report) last announced its earnings results on Tuesday, January 28th. The medical instruments supplier reported $0.86 EPS for the quarter. Utah Medical Products had a return on equity of 11.07% and a net margin of 33.92%.
Utah Medical Products Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Thursday, April 3rd. Stockholders of record on Friday, March 14th were paid a dividend of $0.305 per share. This represents a $1.22 dividend on an annualized basis and a dividend yield of 2.33%. The ex-dividend date of this dividend was Friday, March 14th. Utah Medical Products's payout ratio is 30.89%.
Utah Medical Products Profile
(
Free Report)
Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.
Featured Stories
Before you consider Utah Medical Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Utah Medical Products wasn't on the list.
While Utah Medical Products currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
